Answer
Therapeutic monitoring should be considered when belimumab is started or stopped in patients taking warfarin, a narrow-therapeutic-index CYP substrate whose dose is individually adjusted.
Sources for this answer
- Benlysta 120 mg and 400 mg powder for concentrate for solution for infusionGlaxoSmithKline UK · emc · SmPC §4.5 Interaction with other medicinal products · Version 35Document updated
Sources checked